Sign in

CIK 0001660334

  • Non-accelerated filer
  • Smaller reporting company

Verrica Pharmaceuticals Inc.

Sign in to watch
Ticker
VRCA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
463137900
Phone
+1 484-453-3300
Business address
44 WEST GAY STREET, SUITE 400, WEST CHESTER, PA
  1. 4 Derivatives Options or other derivatives
  2. 4 Open-market buy President and CEO bought 4,000 shares at $9.95 ($39,800)
  3. 4 Open-market buy Chief Legal Officer bought 2,500 shares at $9.79 ($24,475)
  4. 4 Open-market buy Chief Financial Officer bought 5,000 shares at $9.89 ($49,450)
  5. 4 Open-market buy Director bought 739,830 shares at $14.75 ($10,912,493)
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Open-market buy Director bought 10,000 shares at an average $8.88 ($88,785)
  12. 4 Open-market buy Director bought 20,000 shares at $9.09 ($181,800)
  13. 4 Open-market buy Director bought 10,000 shares at $8.55 ($85,500)
  14. 4 Open-market buy Director bought 6,000 shares at $6.92 ($41,520)
  15. 4 Open-market buy Director bought 31,250 shares at an average $6.41 ($200,464)
  16. 4 Open-market buy Chief Financial Officer bought 7,900 shares at $6.24 ($49,296)
  17. 4 Open-market buy President and CEO bought 10,661 shares at $6.28 ($66,951)
  18. 4 Open-market buy Director bought 158,500 shares at an average $6.44 ($1,020,985)
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 7 of 13 · 253 filings